The Cambridge Healthtech Institute SCOPE (Summit for Clinical OPS Executives) Attendee Masterfile reaches executives from leading Pharma, CRO and Biotech companies. This audience may be targeted by postal, email and online display.
|10,419||Total Universe / Universe Rate||$195.00/M|
|8,448||U.S. Postal Subscribers||$195.00/M|
The SCOPE (Summit for Clinical OPS Executives) Attendee Masterfile is comprised of executives from leading Pharma, CRO and Biotech companies. Industry leaders and key decision makers representing 19 different countries and more than 518 unique organizations convene to share case studies, collaborate on best practices and provide unique perspectives on poignant issues facing Clinical OPS. Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people.
These professionals are focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Lab Services, Precision Medicine and Biomarker-Driven Trials.
Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. They report on innovative technologies from clinical trials to medical informatics and cover the application of informatics, IT and computer science in biomedical research and drug discovery.
Job Function (20.00/M) Director 3,354 Executive 2,557 Manager 2,456 Scientist / Technologist 1,692 Primary Business (20.00/M) Biotechnical 2,529 CRO 2,353 Pharmaceutical-Big 2,165